Skip to main content
          Skip to FDA Search
          Skip to in this section menu
          Skip to footer links


U.S. flagAn official website of the United States government

					Here’s how you know
          			Dot gov**The .gov means it’s official.**Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you're on a federal government site.
							      SSL**The site is secure.** The **https://** ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely. 
			U.S. Food and Drug Administration
				
        Search
            Menu
							
						Search FDA
									
									Submit search 
		Featured
							Contact FDA
	                FDA Guidance Documents
	                Recalls, Market Withdrawals and Safety Alerts
	                Press Announcements
	                Warning Letters
	                Advisory Committees
	                En Español

					Products
            Food
							Drugs
							Medical Devices
							Radiation-Emitting Products
							Vaccines, Blood, and Biologics
							Animal and Veterinary
							Cosmetics
							Tobacco ProductsTopics
            About FDA
							Combination Products
							Regulatory Information
							Safety
							Emergency Preparedness
							International Programs
							News and Events
							Training and Continuing Education
							Inspections and Compliance
							Science and ResearchInformation For
            Consumers
	            Patients
	            Industry
	            Health Professionals
	            Federal, State and Local Officials 
 In this section:

                Center for Drug Evaluation and Research | CDER

Center for Drug Evaluation and Research | CDER
            
                        CDER Offices and Divisions
          Meeting Presentations | Drugs
          CDER Exclusivity Board


                        Accelerating Rare disease Cures (ARC) Program
          CDER Contact Information
          CDER Manual of Policies & Procedures | MAPP
          Frequently Asked Questions about CDER
          Reports & Budgets | CDER Home
          About FDA
          FDA Organization
          Center for Drug Evaluation and Research | CDER
          CDER Division of Drug InformationCenter for Drug Evaluation and Research | CDER CDER Division of Drug Information

    
Subscribe to Email Updates
    Share
    Post
    Linkedin

    Email
    PrintWho We Are

The Division of Drug Information (DDI) is CDER's focal point for public inquiries and serves to provide timely, accurate, and useful information about human drug products through traditional and social media channels. DDI’s team of pharmacists and other health care professionals provide education to the general public as well as targeted audiences such as small business, industry and health care professionals.

What We Do

Interact with the public on all aspects of the Center’s activities -- engagement may be in the form of phone, email, social media, or mail.
	Lead the CDER Small Business and Industry Assistance (SBIA) program by providing information about the development and regulation of human drug products to domestic and international pharmaceutical companies. Also on LinkedIn.
	Use social media to communicate and engage with the public. DDI is on X, LinkedIn, Facebook, Instagram, and Threads.
	Produce FDA Drug Info Rounds, a series of videos for health care professionals.
	Produce four podcast series: Q&A with FDA about the top inquiries received by FDA, Drug Safety podcasts about emerging safety information, CDER SBIA Chronicles podcasts about drug marketing and regulation, Drug Information Soundcast in Clinical Oncology (D.I.S.C.O.) about new product approvals and emerging safety information for cancer treatments.
	Educate audiences through the CDERLearn program. Delivering Division of Drug Information Webinars for health care professionals and students. Both programs offer continuing education credit for nurses, nurse practitioners, pharmacists, pharmacy technicians, physicians, and physician assistants.
	Update and manage the Drug Safety-related Labeling Changes (SrLC) database, providing safety data to the public in downloadable and searchable formats.
	Update and manage the REMS@FDA database of currently approved individual and shared system Risk Evaluation and Mitigation Strategies (REMS). This database provides REMS information and data to the public in downloadable and searchable formats.
	Connect pharmacists specializing in drug information to the Global Alliance of Drug Information Specialists (GADIS) online collaborative community.
	Administer the FDA Pharmacy Student Experiential Program, offering Advanced Pharmacy Practice Experience rotations to student pharmacists.
	Lead the Regulatory Pharmaceutical Fellowship, a two-year program for PharmD’s offering specialized experiences in partnership with academia and pharmaceutical industry.Contact Us

Email: druginfo@fda.hhs.gov | Telephone: 855-543-3784
	Email: CDERSBIA@fda.hhs.gov | CDER SBIA Phone: 866-405-5367
	Hillandale Building 10001 New Hampshire Avenue Silver Spring, MD 20993Spotlight

Index to Drug-Specific Information
	Information for Consumers (Drugs)
	Information for Healthcare Professionals (Drugs)
	Information for Industry (Drugs)
	Report a Serious Medical Product Problem Online
	DailyMed (National Library of Medicine)
	Drugs@FDA
	Frequently Asked Questions About Drugs
	Drug IdentificationResources

Regulatory Pharmaceutical Fellowship (including Drug Information)
	FDA Drug Info Rounds
	CDERLearn Training and Education

                                                                                  Content current as of:
      01/17/2024Center for Drug Evaluation and Research | CDER
            
          
                        CDER Offices and Divisions
          Meeting Presentations | Drugs
          CDER Exclusivity Board


                        Accelerating Rare disease Cures (ARC) Program
          CDER Contact Information
          CDER Manual of Policies & Procedures | MAPP
          Frequently Asked Questions about CDER
          Reports & Budgets | CDER
 SUBSCRIBE
                      Get regular FDA email updates delivered on this topic to your inbox.
    Enter your email address to subscribe:
 Footer Links
    FDA Archive
          About FDA
          Accessibility
      Visitor Information
          Website Policies / Privacy
          No FEAR Act
          Vulnerability Disclosure Policy
      FOIA
          HHS.gov
          USA.gov
    Contact FDA
      Follow FDA on Facebook
      Follow FDA on X
      Follow FDA on Instagram
      Follow FDA on LinkedIn
      View FDA videos on YouTube
      Subscribe to FDA RSS feeds
    FDA Homepage
    Contact Number
      1-888-INFO-FDA (1-888-463-6332) Back toTop